Children’s Tumor Foundation: Drug Discovery Initiative (DDI) Awards 2017

DDI Awards represent a critical early-stage doorway into the NF pre-clinical pipeline. The program will support projects that may have no preliminary data but which do have a sound rationale for testing candidate therapeutics in NF cell or mouse models.

The goal for these projects is to go on and secure larger grants from federal or private sources to continue progress.

Funding & Duration

Awards will provide up to US $40,000 (approx AUD $52,600) to fund in-vitro cell-based pre-clinical drug testing studies; or up to US $85,000 (approx. AUD $112,000) to fund in-vivo animal-based preclinical drug testing studies.

Eligibility

Applicant should have an MD, Ph.D. or equivalent and have full access to, or identified collaborators with, all required resources including all in vivo and in vitro models.

There are no citizenship requirements for this program. Applications are welcomed from all qualified individuals worldwide.

Applications are welcomed from both the academic and private sectors. Partnerships between the two are actively encouraged.

Submission Requirements & Due Date

Further Information

Need Help?

This entry was posted in Engineering, Computer & Mathematical Sciences, Funding by Award Type, Funding by Faculty, Grants (Project Funds), Health & Medical Sciences, International Funding, Sciences. Bookmark the permalink.

Comments are closed.